Medical management of peripheral arterial disease

被引:34
作者
Bendermacher, BLW
Willigendael, EM
Teijink, JAW
Prins, MH
机构
[1] Univ Maastricht, KEMTA, Dept Epidemiol, NL-6229 HX Maastricht, Netherlands
[2] Maasland Hosp, Dept Surg, Sittard, Netherlands
[3] Atrium Med Ctr, Dept Surg, Div Vasc Surg, Heerlen, Netherlands
关键词
antiplatelet; atherosclerosis; claudication; critical limb ischemia; management; secondary prevention;
D O I
10.1111/j.1538-7836.2005.01368.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Whether symptomatic or not, peripheral arterial disease (PAD), atherosclerosis in the arteries of the lower extremities, is a common disorder in the general population. The prevalence increases with age and under the influence of vascular risk factors. The most classic symptomatic expression of PAD is intermittent claudication. However, the majority of patients with PAD is asymptomatic or has leg symptoms other than classic intermittent claudication. Both symptomatic and asymptomatic subjects with PAD have increased mortality rates, mainly due to cardiovascular and cerebrovascular expressions of atherosclerotic disease. This review focuses oil the current available medical therapies for PAD, including risk-factor modification and antiplatelet therapies, as well as strategies for symptomatic relief in both patients with intermittent claudication and patients with critical limb ischemia. In general, risk factor modification and antiplatelet therapy is essential in all patients with PAD to prevent systemic atherosclerotic complications. Furthermore. for symptomatic relief exercise therapy is the main intervention while pharmacological treatment should be only complementary. In patients with critical limb ischemia, when revascularization therapy is not possible, an attempt should be made to avoid amputation with conservative treatment using analgesics, vasodilators and/ or anticoagulants. In case of an acute onset of critical limb ischemia, thrombolysis is indicated.
引用
收藏
页码:1628 / 1637
页数:10
相关论文
共 139 条
[31]  
Dormandy J, 1999, Semin Vasc Surg, V12, P123
[32]  
Doyle Jeanne, 2003, Rev Cardiovasc Med, V4, P18
[33]   Peripheral artery occlusion: Treatment with abciximab plus urokinase versus with urokinase alone - A randomized pilot trial (the PROMPT study) [J].
Duda, SH ;
Tepe, G ;
Luz, O ;
Ouriel, K ;
Dietz, K ;
Hahn, U ;
Pereira, P ;
Marsalek, P ;
Ziemer, G ;
Erley, CM ;
Claussen, CD .
RADIOLOGY, 2001, 221 (03) :689-696
[34]  
DUFFIELD RGM, 1983, LANCET, V2, P639
[35]   EPIDEMIOLOGY OF LEG AMPUTATION - THE INFLUENCE OF VASCULAR-SURGERY [J].
EBSKOV, LB ;
SCHROEDER, TV ;
HOLSTEIN, PE .
BRITISH JOURNAL OF SURGERY, 1994, 81 (11) :1600-1603
[36]   Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication [J].
Elam, MB ;
Heckman, J ;
Crouse, JR ;
Hunninghake, DB ;
Herd, JA ;
Davidson, M ;
Gordon, IL ;
Bortey, EB ;
Forbes, WP .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (12) :1942-1947
[37]   Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease - The ADMIT Study: A randomized trial [J].
Elam, MB ;
Hunninghake, DB ;
Davis, KB ;
Garg, R ;
Johnson, C ;
Egan, D ;
Kostis, JB ;
Sheps, DS ;
Brinton, EA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1263-1270
[38]   PENTOXIFYLLINE FOR INTERMITTENT CLAUDICATION A CRITICAL-REVIEW [J].
ERNST, E .
ANGIOLOGY, 1994, 45 (05) :339-345
[39]   THE EFFECTIVENESS OF THE NICOTINE PATCH FOR SMOKING CESSATION - A METAANALYSIS [J].
FIORE, MC ;
SMITH, SS ;
JORENBY, DE ;
BAKER, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (24) :1940-1947
[40]  
Fiore MC., 2000, TREATING TOBACCO USE